
Several GSI/FAIR research areas receive EU funding in the millions. Four planned infrastructure projects in the fields of tumor therapy with heavy ions, innovative methods for industrial radiation testing and new technology developments for accelerator facilities were successful in current EU tenders and have received funding commitments. FAIR and GSI play a decisive role in each of these projects, which are carried out in international collaborations.

Jörg Blaurock will continue his successful work as Technical Managing Director of GSI Helmholtzzentrum für Schwerionenforschung GmbH and Facility for Antiproton and Ion Research in Europe GmbH (FAIR GmbH) for the next five years. His second term has begun on February 1, 2021. The FAIR Council and the GSI Supervisory Board have acknowledged his achievements and expressed their wish for him to continue for another term.

The GSI Helmholtzzentrum and the future accelerator center FAIR start the New Year with an exciting new digital offer: Beginning in February, special online visits will be organized. The live moderated events offer a comprehensive insight into current research and the experimental facilities at GSI/FAIR and allow questions to be asked and discussed in real time. Also included is an exclusive view at the mega construction site for the future accelerator center FAIR, one of the largest…

An international research team succeeded in gaining new insights into the artificially produced superheavy element flerovium, element 114, at the accelerator facilities of the GSI Helmholtzzentrum für Schwerionenforschung in Darmstadt, Germany. Under the leadership of Lund University in Sweden and with significant participation of Johannes Gutenberg University Mainz (JGU) as well as the Helmholtz Institute Mainz (HIM) in Germany and other partners, flerovium was produced and investigated.

As part of corona prevention, GSI and FAIR decided in March to suspend the lectures of the series “Wissenschaft für Alle” until further notice. Since the lecture events can still not be held on the campus, a digital offer is now taking their place. Starting December, the speakers will offer their lectures as video conferences. Interested parties can join in via a dial-in link using a web-enabled device.

This year, the Christoph Schmelzer Award goes to two young female scientists: The medical physicist Dr. Alina Bendinger from the German Cancer Research Center DKFZ Heidelberg and the engineer Dr. Giorgia Meschini from the biomedical department of the State Polytechnic University in Milan (Politecnico di Milano) receive the prize in recognition of their doctoral theses. With this award, the Association for the Promotion of Tumor Therapy with Heavy Ions e.V. annually honors outstanding master's…

The laser physicist Dr. Jan Rothhardt from the Helmholtz Institute Jena (HI Jena), an institute of the GSI Helmholtzzentrum für Schwerionenforschung, located on the campus of the Friedrich Schiller University (FSU) Jena, receives the renowned Röntgen Prize. The prize will be awarded during the digital academic ceremony of the Justus-Liebig-University Gießen. The 39-year-old leader of a Helmholtz Young Investigator Group, who works at HI Jena and the Friedrich Schiller University of Jena,…

Bringing huge amounts of protons up to speed in the shortest distance in fractions of a second — that's what laser acceleration technology, greatly improved in recent years, can do. An international research team has succeeded in using protons accelerated with the GSI high-power laser PHELIX to split other nuclei and to analyze them. The results could provide new insights into astrophysical processes.
Perspectives of tumor treatment: Researchers investigate combination of carbon ion and immunotherapy

It is still a glance into the future: The combination of carbon ion and immune therapy could become an effective tool in the fight against cancer. Promising results for the potential benefit of this treatment combination have now been published in the renowned radiation therapy journal "International Journal of Radiation Oncology, Biology, Physics" of the American Society for Therapeutic Radiation Oncology (ASTRO). The authors are an international team of researchers, led by the Department of…